Eli Lilly and Company (LLY) Eli Lilly (NYSE: LLY) Acquire Protomer Technologies Eli Lilly and Company (NYSE: LLY) disclosed on Wednesday that it has acquired Protomer Technologies. Protomer is a private biotech firm whose peptide- and protein-engineering platform is utilized to recognize
Eli Lilly and Company (LLY) Eli Lilly (NYSE: LLY) To Provide Additional Doses Of Neutralizing Antibody Therapy To US Eli Lilly and Company (NYSE: LLY) disclosed that the US government has informed the firm that authorities will buy at least 100,000 doses of bamlanivimab 700 mg and etesevimab 1400 mg together.
Regeneron Pharmaceuticals Inc Regeneron (NASDAQ: REGN) To Deliver Antibody Drug To Czech Ahead Of EU Registration Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is preparing to deliver 12, 000 antibody treatment to the Czech Republic before the authorization of the EU.
$LLY Eli Lilly' (NYSE: LLY) Baricitinib Gets Emergency Use Authorization From FDA Eli Lilly and Company (NYSE: LLY) revealed today that FDA has awarded emergency use authorization to its arthritis drug Baricitinib in combination with Gilead Sciences’ remdesivir for the treatment of COVID-19 patients in the hospital. FDA has allowed the emergency use for the